How well does Xiidra(Lifitegrast) work?

The document confirms bioequivalence and therapeutic equivalence to the reference drug but does not detail the specific therapeutic effects.

Therapeutic Efficacy and Clinical Role

According to the document, Lifitegrast Ophthalmic Solution, 5% has been determined by the FDA to be bioequivalent and therapeutically equivalent to Xiidra Ophthalmic Solution, 5% (Novartis). This indicates that the generic product is expected to provide the same clinical benefit and safety profile as the reference listed drug. However, the document does not elaborate on the specific therapeutic effects, indications, or clinical outcomes associated with its use. Thus, the therapeutic effect is "not specified in the description" beyond equivalence to the reference product.